High throughput assays for analyzing transcription factors

Assay and Drug Development Technologies

Volumn 4, Issue 3, 2006, Pages 333-341

  Li, Xianqing ^a   Jiang, Xin ^a   Yaoi, Takuro ^a  

^a Panomics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BETA GALACTOSIDASE; CHOLESTEROL ESTER TRANSFER PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; ENHANCED GREEN FLUORESCENT PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LUCIFERASE; MICROSPHERE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR REL; TUMOR NECROSIS FACTOR ALPHA;

CELL DIFFERENTIATION; CELL GROWTH; DISEASE ASSOCIATION; DNA MICROARRAY; DRUG IDENTIFICATION; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; GENETIC ANALYSIS; HELA CELL; HIGH THROUGHPUT SCREENING; HUMAN; MOUSE; NONHUMAN; PROTEIN INTERACTION; PROTEIN MICROARRAY; REPORTER GENE; REVIEW;

BIOLOGICAL ASSAY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN ARRAY ANALYSIS; PROTEIN INTERACTION MAPPING; TRANSCRIPTION FACTORS;

EID: 33746114178     PISSN: 1540658X     EISSN: None     Source Type: Journal    
DOI: 10.1089/adt.2006.4.333     Document Type: Review

References (33)

1. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, et al.: The sequence of the human genome. Science 2001;291:1304-1351. [Erratum in Science 2001; 292:1838.]
2. Brown PO, Botstein D: Exploring the new world of the genome with DNA microarrays. Nat Genet 1999;21:33-37.
3. Debouck C, Goodfellow PN: DNA microarrays in drug discovery and development. Nat Genet 1999;21:48-50.
4. Gygi SP, Rochon Y, Franza BR, Aebersold R: Correlation between protein and mRNA abundance in yeast. Mol Cell Biol 1999;19:1720-1730.
5. Jones N: Structure and function of transcription factors. Semin Cancer Biol 1990;1:5-17.
6. Emerson BM: Specificity of gene regulation. Cell 2002;109:267-270.
7. Sawyer TK: Deciphering therapeutic targets. Biotechniques 2001;30:1086-1088, 1090.
8. Benz C: Transcription factors and breast cancer. Endocr Relat Cancer 1998;5:271-282.
9. Boyd KE, Farnham PJ: Identification of target genes of oncogenic transcription factors. Proc Soc Exp Biol Med 1999;222:9-28.
10. Shi Yu Z: E2F-1: a proliferative marker of breast neoplasia cancer. Epidemiol Biomarkers Prev 2000;9:395-401.
11. Chen TK, Smith LM, Gebhardt DK, Birrer MJ, Brown PH: Activation and inhibition of the AP-1 complex in human breast cancer cells. Mol Carcinog 1996;15:215-226.
12. Garg A, Aggarwal BB: Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia 2002;16:1053-1068.
13. Barnes PJ, Karin M: Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066-1071.
14. Dumont A, Hehner SP, Schmitz ML, Gustafsson JA, Liden J, Okret S, van der Saag PT, Wissink S, van der Burg B, Herrlich P, Haegeman G, De Bosscher K, Fiers W: Cross-talk between steroids and NF-kappa B: what language? Trends Biochem Sci 1998;23:233-235.
15. Heck S, Bender K, Kullmann M, Gottlicher M, Herrlich P, Cato AC: I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor. EMBO J 1997;16:4698-4707.
16. Olson EN, Schneider MD: Sizing up the heart: development redux in disease. Genes Dev 2003;17:1937-1956.
17. Semenza GL: HIF-1 and human disease: one highly involved factor. Genes Dev 2000;14:1983-1991.
18. Kiberstis PA: BIOMEDICINE: morphing into metastasis. Science 2004;305:19d.
19. Memon RA, Tecott LH, Nonogaki K, Beigneux A, Moser AH, Grunfeld C, Feingold KR: Up-regulation of peroxisome proliferator-activated receptors (PPAR-alpha) and PPAR-gamma messenger ribonucleic acid expression in the liver in murine obesity: troglitazone induces expression of PPAR-gamma-responsive adipose tissue-specific genes in the liver of obese diabetic mice. Endocrinology 2000;141: 4021-4031.
20. Gottlicher M, Heck S, Herrlich P: Transcriptional crosstalk, the second mode of steroid hormone receptor action. J Mol Med 1998;76:480-489.
21. Berns A: Gene expression in diagnosis. Nature 2000;403: 491-492.
22. Jiang X, Roth L, Lai C, Li X: Profiling activities of transcription factors in breast cancer cell lines. Assay Drug Dev Technol 2006;4:293-305.
23. Giebler HA, Lemasson I, Nyborg JK: p53 recruitment of CREB binding protein mediated through phosphorylated CREB: a novel pathway of tumor suppressor regulation. Mol Cell Biol 2000;20:4849-4858.
24. Vaishnav YN, Pant V: Differential regulation of E2F transcription factors by p53 tumor suppressor protein. DNA Cell Biol 1999;18:911-922.
25. Liu J, Grogan L, Nau MM, Allegra CJ, Chu E, Wright JJ: Physical interaction between p53 and primary response gene Egr-1. Int J Oncol 2001;18:863-870.
26. Stuart ET, Haffner R, Oren M, Gruss P: Loss of p53 function through PAX-mediated transcriptional repression. EMBO J 1995;14:5638-5645.
27. Sala A, Casella I, Grasso L, Bellon T, Reed JC, Miyashita T, Peschle C: Apoptotic response to oncogenic stimuli: cooperative and antagonistic interactions between c-myb and the growth suppressor p53. Cancer Res 1996;56:1991-1996.
28. Budhram-Mahadeo V, Morris PJ, Smith MD, Midgley CA, Boxer LM, Latchman DS: p53 suppresses the activation of the Bcl-2 promoter by the Brn-3a POU family transcription factor. J Biol Chem 1999;274:15237-15244.
29. Furlong EE, Rein T, Martin F: YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity. Mol Cell Biol 1996;16:5933-5945.
30. Koutsodontis G, Tentes I, Papakosta P, Moustakas A, Kardassis D: Sp1 plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAF1/Cip1) gene by the p53 tumor suppressor protein. J Biol Chem 2001;276:29116-29125.
31. Yaoi T, Jiang X, Li X: Development of a fluorescent microsphere-based multiplexed high-throughput assay system for profiling transcription factor activation. Assay Drug Dev Technol 2006;4:285-292.
32. Smith AD, Sumazin P, Das D, Zhang MQ: Mining ChIP-chip data for transcription factor and cofactor binding sites. Bioinformatics 2005;21(Suppl 1):i403-i412.
33. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young RA: Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005;122:947-956.